| Literature DB >> 24675909 |
Mariana C Ferreira1, Débora Bevilaqua-Grossi2, Fabíola E Dach3, José G Speciali3, Maria C Gonçalves4, Thais C Chaves5.
Abstract
BACKGROUND: Migraine and temporomandibular disorders (TMDs) are reported to be associated. However, there are no reports on the association among migraines, TMDs and changes in body posture.Entities:
Mesh:
Year: 2014 PMID: 24675909 PMCID: PMC4183235 DOI: 10.1590/s1413-35552012005000137
Source DB: PubMed Journal: Braz J Phys Ther ISSN: 1413-3555 Impact factor: 3.377
Mean values (standard deviations, SD) of the anthropometric data and descriptions of the clinical data of the studied samples.
| Variables/Groups | Migraine + TMD (n=22) | Migraine (n=22) | Control (n=22) | P-level[ |
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | ||
| Age (years) | 30.27 (11.46) | 31.72 (9.82) | 24.41 (6.95) | NS |
| Height (m) | 1.65 (0.06) | 1.65 (0.05) | 1.65 (0.08) | NS |
| Weight (kg) | 62.31 (8.15) | 66.81 (18.69) | 63.64 (10.75) | NS |
| Raw values | ||||
| Time of onset of disease (years) | 11.5 | 14.3 | NA | |
| Days of migraine attacks | 7.8 | 8.3 | NA | |
| Side of headache complaint | ||||
| R | 8 | 6 | NA | |
| L | 3 | 3 | NA | |
| Bilateral/Unilateral | 11 | 13 | NA | |
| TMD mixed | ||||
| Group Ia/IIa[ | 14 | 0 | 0 | |
| Group Ib/IIb[ | 1 | 0 | 0 | |
| Group Ia/IIc[ | 4 | 0 | 0 | |
| Myogenous TMD | ||||
| Group Ia[ | 3 | 0 | 0 | |
NA = not applicable; NS = not significant
ANOVA (p <0.05);
Description of RDC/TMD diagnostics subgroups Group I - Myogenous Diagnosis: Ia - Ib and Myofascial Pain - Myofascial pain with limited opening. Group II - Disc Displacement: IIa - disc displacement with reduction; IIb - disc displacement without reduction and with limited opening; and IIIc- disc displacement without reduction and without a limited opening. Group III - Arthralgia, Arthritis and Osteoarthritis: IIIa - Arthralgia; IIIb - IIIc and TMJ Osteoarthritis - Osteoarthritis of the TMJ.
Figure 1A) Schematic picture demonstrating the 21 anatomical points considered for postural analysis. B) Illustrative scheme from a sagittal view. forward head posture(FHP), cervical lordosis angle (CLA), thoracic kyphosis angle (TKA), and Lumbar lordosis angle (LLA). Anatomical points considered: 1 - sternoclavicular joints; 2 - anterosuperior iliac spines; 3 - anterior tibial tuberosity; 4 - second toe, metatarsophalangeal joint; 5 - tragus of the ear; 6 - acromion of scapula; 7 - lateral epicondyle of elbow; 8 - metacarpophalangeal joint of the 3rd finger; 9 - greater trochanter; 10 - head of fibula; 11 - malleolus lateral ankle; 12 - occipital protuberance; 13 - third cervical vertebra; 14 - 7th cervical vertebra; 15- seventh thoracic vertebrae; 16 - twelfth thoracic vertebra; 17- third lumbar vertebra; 18- fifth lumbar vertebra; 19 - posterior superior iliac spines; 20 - posterior inferior iliac spines; and 21 - midpoint of poplietal line.
Description of the method of measurement of the 19 angles considered and their benchmarks.
| Angle | Acronym | Obtaining/Reference Values (x = angle) | |
|---|---|---|---|
| Angles Frontal Plane - Face and Shoulder Girdle / Anterior View / Posterior View | |||
| Internal Orbicular Angle | IO | ||
| External Orbicular Angle | EO | Measured from left to right and extending forward on the horizontal | |
| Comissura Labiorum Angle | CLA | ||
| Acromion-Clavicular joint Angle | AC | ||
| Sternoclavicular Joint Angle | SC | X = 180: value measured | |
| Angle of Ear Tragus | AET | Value = 180: absence of asymmetry | |
| Anterior Superior Iliac Spines Angle | AS | Values <180: Suggests tilt to the left | |
| Angle between the Tibial Protuberance | ATP | Values> 180: suggested tilt to right | |
| Inferior Angle of the Scapula | IS | ||
| Central Region of Olecranon Angle | OC | ||
| Posterior Superior Iliac Spines Angle | PS | ||
| Posterior Inferior Iliac spines Angle | PI | ||
| Popliteal Line Angle | PL | ||
|
|
| ||
| Forward Head Posture (FHP) | Measured from the tragus of the ear to the spinous
process of C7, extending forward on the horizontal
line.[ | ||
| Cervical lordosis (CL) | Angle formed by the straight lines between the
occipital protuberance and the spinous process of C7 that
intersects the horizontal line between C4 and the true vertical
line - plumb line | ||
| Thoracic kyphosis (TKA) | Angle formed by the straight lines between the
spinous process of C7 and T12 that intersect the horizontal line
between T7 and the true vertical line[ | ||
| Lumbar lordosis (LLA) | Angle formed by the straight lines between the
spinous processes of T12 and L5 that intersect the horizontal
line between L3 and the true vertical line[ | ||
| Knee flexor (KF) | Angle formed by the straight line between the
points on the greater trochanter of the femur and the head of
the fibula and the straight line that passes through the head of
the fibula and extends vertically downwards[ | ||
| Tibiotarsal angle (TTA) | Angle formed by the straight line between the head
of the fibula and the lateral malleolus of the foot and the
straight line that joins the lateral malleolus and the head of
the fifth metatarsus[ | ||
No reference values/**EJ>180: suggested knee hyperextension and EJ<180: suggests knee flexion
Intraclass Correlation Coefficients (ICC), mean values and confidence intervals (95%) of the 19 measured angles (degrees) in the patients with migraines (MG), patients with migraines and temporomandibular disorders (MTMD), and the control group (CG).
| Angles | Mean ICC (CI 95%) | MTMD (n=22) Mean (CI 95%) | MG (n=22) M ean (CI 95%) | CG (n=22) Mean (CI 95%) |
|---|---|---|---|---|
| EO | 0.71 (0.90-0.15) | 181.71 (182.12-181.30) | 182.22 (182.59-181.84)[ | 181.51 (181.86-181.16) |
| IO | 0.76 (0.80-0.40) | 181.24 (181.41-181.07) | 182.21 (182.61-181.96)[ | 181.53 (181.01-181.04) |
| AC | 0.88 (0.96-0.66) | 181.07 (181.24-180.91)[ | 182.29 (182.62-181.96) | 182.48 (182.89-182.08) |
| SC | 0.78 (0.92-0.35) | 181.64 (181.44-181.03) | 182.05 (182.39-181.71)[ | 181.64 (182.04-181.23) |
| AET | 0.82 (0.84-0.49) | 181.11 (181.28-180.94) | 181.75 (182.11-181.39)[ | 181.26 (181.52 - 181) |
| CLA | 0.66 (0.88-0.03) | 181.16 (181.36-180.96) | 181.55 (181.86-181.25) | 181.21 (181.51-180.91) |
| FHP | 0.96 (0.98-0.90) | 67.83 (68.89-66.78) | 69.88 (71.19-68.58) | 73.03 (74.68-71.39)[ |
| CL | 0.79 (0.93-0.39) | 14.63 (15.04-14.23) | 14.99 (15.39-14.59) | 16.38 (17.04-15.72)[ |
| TKA | 0.97 (0.99-0.93) | 40.13 (41.02-39.24)[ | 42.93 (44.60-41.27)[ | 47.27 (49.03-45.51) |
| LLA | 0.93 (0.97-0.81) | 27.19 (28.18-26.20)[ | 25.48 (26.47-24.48)[ | 22.68 (23.32-22.04) |
| KF | 0.99 (1.00-0.99) | 181.53 (183.44-179.62) | 182.26 (183.80-180.72) | 182.02 (184.18-179.86) |
| TTA | 0.98 (0.99-0.96) | 100.31 (101.41-99.20) | 101.00 (102.18-99.82) | 99.47 (101.34-97.60) |
| IS | 0.98 (0.99-0.95) | 181.81 (182.49-181.13) | 181.29 (181.48-180.09) | 179.12 (180.52-177.71)[ |
| OC | 0.88 (0.96-0.66) | 180.86 (181.49-180.22) | 181.03 (181.77-180.29) | 180.02 (180.66-179.38) |
| PS | 0.98 (0.99-0.94) | 181.84 (182.68-180.59) | 181.85 (183.04-180.66) | 180.13 (181.34-178.92) |
| PI | 0.96 (0.98-0.89) | 183.27 (184.48-182.05) | 183.86 (184.97-182.75) | 180.58 (183.04-180.13)[ |
| PL | 0.95 (0.98-0.87) | 182.10 (183.20-181.01) | 182.65 (184.97-182.75) | 179.89 (180.93-178.85)[ |
| AS | 0.86 (0.95-0.60) | 184.40 (183.01-181.36) | 182.23 (184.21-182.26) | 182.95 (184.04-181.85) |
| ATP | 0.76 (0.92-0.31) | 181.76 (181.80-180-87) | 181.95 (181.26-181.62) | 181.48 (181.83-181.13) |
Difference compared to the other groups - ANOVA, p<0.05 and post-hoc Bonferoni. NS: Not Significant. IO - internal orbicular angle; EO - external orbicular angle; CLA - comissura labiorum angle; AC - acromion-clavicular joint angle; SC - sternoclavicular joint angle; AET - angle of ear tragus; AS - anterior superior iliac spines angle; ATP - angle between tibial protuberance; IS - inferior angle of scapula; OC - central region of olecranon angle; PS - posterior superior iliac spines angle; PI - posterior inferior iliac spines angle; PL - popliteal line angle; FHP - forward head posture; CL - cervical Lordosis; TKA - thoracic kyphosis; LLA - lumbar lordosis; KF - knee flexor; TTA - tibiotarsal angle
Mean difference, standard error of measurement (SEM), effect size and minimal important difference for the 19 measured angles (degrees) compared among patients with migraines (MG), patients with migraines and temporomandibular disorders (MTMD), and the control group (CG).
| Angles | Mean Difference (MTMD-CG) | Mean Difference (MG-CG) | Mean Difference (MTMD-MG) | SEM | ES[ | ES[ | ES[ | MID 0.2/0.5 (MTMD vs. CG) | MID 0.2/0.5 (MG vs. CG) | MID 0.2/0.5 (MTMD vs. MG) |
|---|---|---|---|---|---|---|---|---|---|---|
| EO | 0.20 | 0.71[ | –0.50[ | 0.45 | –0.13 = SES | –0.49=MES | –0.30 = SES | 0.31/0.79 | 0.29/0.72 - PCR | 0.34/0.84 |
| IO | –0.28 | 0.68[ | –0.97[ | 0.57 | 0.20 = SES | –0.31=SES | –0.92 = LES | 0.29/0.73 | 0.44/1.09 | 0.21/0.53- CR |
| AC | –1.41[ | –0.20 | –1.21[ | 0.34 | 1.36 = LEF | 0.13=SES | –1.63 = LES | 0.21/0.52 - CR | 0.30/0.75 | 0.15/0.37 - CR |
| SC | –0.40 | 0.41[ | –0.82[ | 0.56 | 0.36 = SES | –0.27=SES | –0.95= LES | 0.23/0.56 | 0.30/0.75 | 0.17/0.43 - CR |
| AET | –0.15 | 0.48[ | –0.64[ | 0.30 | 0.28 = SES | –0.44=MES | –0.73= LES | 0.11/0.27 | 0.22/0.55 - PCR | 0.17/0.43 - CR |
| CLA | –0.05 | 0.34 | –0.40 | 0.25 | 0.07 = SES | –0.34=SES | –0.54 = MES | 0.14/0.35 | 0.20/0.50 | 0.15/0.37 - CR |
| FHP | –5.20[ | –3.15[ | –2.05 | 0.79 | 0.25 = SES | 0.13=SES | –0.13 = SES | 4.17/10.44 | 4.81/12.04 | 3.08/7.71 |
| CLA | –1.75[ | –1.38[ | –0.36 | 0.73 | 0.53 = MES | 0.42=MES | –0.20 = SES | 0.66/1.65 - CR | 0.66/1.64 - CR | 0.35/0.89 |
| TKA | –7.14[ | –4.34[ | –2.81 | 0.73 | 0.34 = SES | 0.14=SES | –0.14 = SES | 4.24/10.61 | 6.39/15.99 | 3.88/9.70 |
| LLA | 4.51[ | 2.79[ | 1.71 | 0.31 | –0.60=MES | –0.37= SES | 0.16=SES | 1.51/3.79 - CR | 1.53/3.82 | 2.15/5.37 |
| KF | –0.49 | 0.24 | –0.73 | 1.04 | 0.01=SES | –0.01=SES | –0.02=SES | 9.10/22.76 | 7.71/19.28 | 6.59/16.47 |
| TTA | 0.84 | 1.53 | –0.69 | 0.90 | –0.03=SES | –0.06=SES | –0.05=SES | 5.16/12.90 | 5.36/13.39 | 2.86/7.14 |
| IS | 2.69 | 2.17 | 0.52 | 0.48 | –0.20=SES | –0.12=SES | 0.05=SES | 2.67/6.68 | 3.73/9.33 | 2.07/5.18 |
| OC | 0.84 | 1.01 | –0.18 | 0.53 | –0.19=SES | –0.19=SES | –0.03=SES | 0.89/2.23 | 1.05/2.62 | 1.05/2.61 |
| PS | 1.51 | 1.72 | –0.21 | 0.41 | –0.11=SES | –0.11=SES | –0.02=SES | 2.79/6.98 | 3.14/7.85 | 2.73/6.84 |
| PI | 1.68 | 2.28 | –0.59 | 0.70 | –0.09=SES | –0.12=SES | –0.04=SES | 3.92/9.81 | 3.67/9.18 | 2.96/7.40 |
| PL | 2.22 | 2.76 | –0.54 | 0.56 | –0.18=SES | –0.21=SES | –0.04=SES | 2.48/6.21 | 2.61/6.53 | 2.74/6.85 |
| AS | –0.76 | 0.29 | –1.05 | 0.98 | 0.07=SES | –0.04=SES | –0.12=SES | 2.06/5.15 | 1.32/3.30 | 1.79/4.46 |
| ATP | –0.14 | 0.47 | –0.62 | 0.41 | 0.08=SES | –0.71= MES | –0.35=SES | 0.37/0.92 | 0.13/0.34 - CR | 0.35/0.88 |
Significant difference - ANOVA, p<0.05 and post-hoc Bonferoni. Scoring criteria: When the effect size (ES) and the mean difference between the groups were higher than the minimal important difference (MID), the difference was considered clinically relevant (CR). If the ES is moderate and the mean difference between the groups is greater than the MID, then the measure was classified as potentially clinically relevant (PCR). If the ES is small / moderate and the average difference between the groups is greater than both MIDs, the measurement is classified as PCR. If the ES is small and the average difference between the groups is greater than the MID, the measure cannot be termed clinically relevant. If the ES is small and the average difference between the groups is smaller than the MID, the measure is classified as not clinically relevant. Rating
The effect sizes followed the recommendation of Cohen37 - small ES (SES): 0:20 (0-0.39); moderate Effect Size: 0.50 (0.4-0.79); large ES:>0.80, ES: effect size, MID: minimal important difference, PCR: Potentially clinically relevant, CR: clinically relevant, SES: small effect size, MES: moderate effect size, LEF: large effect size.